SlideShare a Scribd company logo
1 of 22
 Despite therapeutic advances during this century and a
  growing perception of the safety of child birth, morbidity and
  mortality continue to occur in obstetric patients. More than
  one woman dies every TEN minute from such causes.
 In addition to maternal death, women experience more than
  50 million maternal health problems annualiy.
 As many as 300 million women-more than one quarter of all
  adult women living in the developing world currently suffer
  from short or Iong term illness and injuries related to
  pregnancy and child birth.
 For every maternal death there are many serious life
  threatening complications of pregnancy.
 Yet relatively little attention has been given to identifying a
  general category of morbidity that could be called near-misses
 The analysis of maternal deaths has long been used for the
  evaluation of women’ ’s health and the qualityof obstetric care

 Over the last decade, the identification of cases of severe
  maternal morbidity has emerged as a promising complement
  or alternative to the investigation of maternal deathS.

 It has been suggested that with the observed decline in
  maternal mortality, analysis of well defined near-miss cases
  may be a more sensitive measure of the standard of obstetric
  care.

 Incorporation of near-misses into maternal death enquiries
  would strengthen these audits by allowing for more rapid
  reporting; more robust conclusions, comparisons to be made
  with maternal deaths, reinforcing lessons learnt, establishing
  requirement for intensive care and calculating comparative
  indices
WHATS A NEAR MISS?
 Every woman can experience sudden
  and unexpected complications during
  pregnancy, child birth and just after
  delivery.

 Morbidity during pregnancy represents
  part of a continuum between extremes
  of good health and death.

 On this continuum a pregnancy may be
  thought of as being uncomplicated,
  complicated, severely complicated or life
  threatening
 Near Miss Maternal Mortality is a term which is very
  difficult to define.Any pregnant women or recently
  delivered women within 6 weeks of delivery or
  termination of pregnancy in whom immediate
  survival is threatened and who survives by the
  medical intervention and hospital care can be termed
  as Near Miss
 By Mantel GD et al, a near miss describes a patient
  with acute organ system dysfunction, which if not
  treated appropriately, could result in death.
 Prual A et al, has defined severe maternal morbidity
  as severe complications from 28th week of gestation
  to 42nd day postpartum that would have resulted in
  death of the mother or a definite invalidating
  sequelae without medical intervention.
 In different studies, the primary obstetric causes of
  severe maternal morbidities have been found to be
  hypertensive disorders of pregnancy, massive obstetric
  haemorrhage.

 Obstructed labour has been found to be an important
  cause in some studies.
Risk factors
The risk factors of severe maternal morbidites have been identified as:
 Maternal age >34
 social exclusion
 Hypertension,
 Previous PPH
 Delivery by emergency caesarean section,
 Multiple pregnancy
 Anaemia
 Low status of women who do not attend antenatal care in a given
  health unit but are referred there when they develop life-threatening
  obstetric complications, contribute significantly to maternal
  morbidity.
 Induced abortions conducted by untrained village midwife (DAI) is
  still a major cause of morbidity in the developing countries
MATERIAL AND METHODS
 222 potentially Life threatening cases were studied in a
  private hospital (Malhotra Nursing Home) in Agra(INDIA)
  in past five years . And we did a comparison with a rural
  hospital where we found out about 1080 potentially life
  threatening cases in past three years.
 The main outcome measures were: rate of near miss and
  its primary determinant factors, criteria for its
  identification, total hospital stay, ICU stay, and number
  and kind of special procedures performed.
 Complete statistical Analysis was done related to the
  causes and preventive measures and hospital recovery
  stay in the study.
OUR STATISTICS


TOTAL NUMBER      Private hospital   Rural Hospital
OF DELIVERIES     (Five years)       (Three years)
(PAST 5 YRS)
NO OF LIVE BIRTHS 1909               6480

NO OF NEAR MISS    32                482

NO OF MATERNAL     0                 9
DEATHS

NO OF LIVE BIRTHS 19                 250
IN NEAR MISS
Private Hospital



               32
              1.67%
Rural Hospital



                           278

          482      287
 6480     (7.4%)         4.29%
MATERNAL MORTALITY- 9
POSSIBLY LIFE   RURAL HOSP           %        PRIVATE           %
THREATENING
                  N= 1080                      N=222
CASES
PRE-        391              36.5%       122            54.5%
ECLAMPSIA/H
ELLP
HAMEORRHA       270          25%         34             15.3%
GE
ABRUPTIO        100          10.8%       14             6.3%
THROMBOCY       78           7.2%        15             6.7%
TOPENIA
INFECTION/SE 154             14.2%       8              3.6%
PSIS
CHD             17           1.5%        8              3.6%
PULMONARY       19           1.7%        5              2.2%
OEDEMA

SICKLE CELL     21           2.0%        4              1.8%
JAUNDICE/DIC 30              2.7%        4              1.8%
NEAR MISS CASES    N =32(private)   %       N=287(rural)   %



INTUBATION AND     16               49%     87             31%
VENTILATION
CLOTTING FAILURE   10               32.2%   30             10.4%

BLOOD              8                25.8%   56             19.51%
TRANSFUSIONS>5
UNITS
THROMBOCYTOPENI    7                22.6%   23             8.2%
A
HYSTERECTOMY       4                12.9%   17             5.9%

RE-EXPLORATION     3                9.7%    29             11%

DIALYSIS           1                3.22%   4              1.3%

SHOCK              6                19.3%   21             7.3%

BILIRUBIN>6mg/dl   4                12.9%   20             7%
MATERNAL
 MORTALITY     0
 IN PRIVATE


 MATERNAL
MORTALITY IN   9
  RURAL
CONCLUSION
 Efforts geared towards improvement in the management of near-miss
  morbidities would definitely go a long way in reducing the present
  maternal mortality ratio.
 From the findings of this review, attempts to reduce maternal deaths
  may best be achieved by developing evidence-based protocols for the
  management of severe hypertension and haemorrhage especially for
  critically ill referred patients.
 In addition, considerable efforts should be made to improve maternal
  care for infrequent but important life-threatening obstetric conditions
  such as uterine rupture and infection. Necessary facilities should be
  made available and training of personnel and emergency drills should
  be frequently conducted to combat the identified disease processes
  that received suboptimal care.
 Although this study did not specifically address avoidable factors, it
  has nevertheless raised awareness of the deficiencies in the
  management of serious maternal illnesses

More Related Content

What's hot

Unexplained Infertility - By Dr Dhorepatil Bharati
Unexplained Infertility - By Dr Dhorepatil BharatiUnexplained Infertility - By Dr Dhorepatil Bharati
Unexplained Infertility - By Dr Dhorepatil BharatiBharati Dhorepatil
 
Recurrent pregnancy loss
Recurrent pregnancy lossRecurrent pregnancy loss
Recurrent pregnancy lossPriya Bhave.
 
ANTENATAL SURVEILLANCE AND MANAGEMENT OF MULTIPLE PREGNANCY – RECENT ADVANCES...
ANTENATAL SURVEILLANCE AND MANAGEMENT OF MULTIPLE PREGNANCY – RECENT ADVANCES...ANTENATAL SURVEILLANCE AND MANAGEMENT OF MULTIPLE PREGNANCY – RECENT ADVANCES...
ANTENATAL SURVEILLANCE AND MANAGEMENT OF MULTIPLE PREGNANCY – RECENT ADVANCES...Lifecare Centre
 
Stem cells in gynecology
Stem cells in gynecologyStem cells in gynecology
Stem cells in gynecologyHesham Al-Inany
 
Role of Stem Cells in Obstetrics and Gynecology Practice
Role of Stem Cells in Obstetrics and Gynecology PracticeRole of Stem Cells in Obstetrics and Gynecology Practice
Role of Stem Cells in Obstetrics and Gynecology PracticeAsha Jain
 
PREGNANCY IN UTERINE PROLAPSE BY DR SHASHWAT JANI
PREGNANCY IN UTERINE PROLAPSE BY DR SHASHWAT JANIPREGNANCY IN UTERINE PROLAPSE BY DR SHASHWAT JANI
PREGNANCY IN UTERINE PROLAPSE BY DR SHASHWAT JANIDR SHASHWAT JANI
 
FIGO guidelines on Placenta Accreta Spectrum Disorders: Conservative manage...
FIGO guidelines on  Placenta Accreta Spectrum Disorders:  Conservative manage...FIGO guidelines on  Placenta Accreta Spectrum Disorders:  Conservative manage...
FIGO guidelines on Placenta Accreta Spectrum Disorders: Conservative manage...Aboubakr Elnashar
 
Fertility preservation
Fertility preservation Fertility preservation
Fertility preservation Hesham Gaber
 
Vulval ca and vulval lymph
Vulval ca and vulval lymphVulval ca and vulval lymph
Vulval ca and vulval lymphhemnathsubedii
 
Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...
Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...
Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...Aboubakr Elnashar
 
Maternal Death Surveillance and Response
Maternal Death Surveillance and Response Maternal Death Surveillance and Response
Maternal Death Surveillance and Response Najib Hamid
 

What's hot (20)

ART PREGNANCY COMPLICATIONS
ART PREGNANCY COMPLICATIONSART PREGNANCY COMPLICATIONS
ART PREGNANCY COMPLICATIONS
 
Unexplained Infertility - By Dr Dhorepatil Bharati
Unexplained Infertility - By Dr Dhorepatil BharatiUnexplained Infertility - By Dr Dhorepatil Bharati
Unexplained Infertility - By Dr Dhorepatil Bharati
 
Recurrent pregnancy loss
Recurrent pregnancy lossRecurrent pregnancy loss
Recurrent pregnancy loss
 
Preterm Labour
Preterm LabourPreterm Labour
Preterm Labour
 
ANTENATAL SURVEILLANCE AND MANAGEMENT OF MULTIPLE PREGNANCY – RECENT ADVANCES...
ANTENATAL SURVEILLANCE AND MANAGEMENT OF MULTIPLE PREGNANCY – RECENT ADVANCES...ANTENATAL SURVEILLANCE AND MANAGEMENT OF MULTIPLE PREGNANCY – RECENT ADVANCES...
ANTENATAL SURVEILLANCE AND MANAGEMENT OF MULTIPLE PREGNANCY – RECENT ADVANCES...
 
Intrapartum sonography
Intrapartum sonographyIntrapartum sonography
Intrapartum sonography
 
Stem cells in gynecology
Stem cells in gynecologyStem cells in gynecology
Stem cells in gynecology
 
HOW TO REDUCE CS RATES?
HOW TO REDUCE CS RATES?HOW TO REDUCE CS RATES?
HOW TO REDUCE CS RATES?
 
Role of Stem Cells in Obstetrics and Gynecology Practice
Role of Stem Cells in Obstetrics and Gynecology PracticeRole of Stem Cells in Obstetrics and Gynecology Practice
Role of Stem Cells in Obstetrics and Gynecology Practice
 
CS scar niche.
CS scar niche.CS scar niche.
CS scar niche.
 
Recurrent pregnancy loss
Recurrent pregnancy loss Recurrent pregnancy loss
Recurrent pregnancy loss
 
PREGNANCY IN UTERINE PROLAPSE BY DR SHASHWAT JANI
PREGNANCY IN UTERINE PROLAPSE BY DR SHASHWAT JANIPREGNANCY IN UTERINE PROLAPSE BY DR SHASHWAT JANI
PREGNANCY IN UTERINE PROLAPSE BY DR SHASHWAT JANI
 
FIGO guidelines on Placenta Accreta Spectrum Disorders: Conservative manage...
FIGO guidelines on  Placenta Accreta Spectrum Disorders:  Conservative manage...FIGO guidelines on  Placenta Accreta Spectrum Disorders:  Conservative manage...
FIGO guidelines on Placenta Accreta Spectrum Disorders: Conservative manage...
 
Fertility preservation
Fertility preservation Fertility preservation
Fertility preservation
 
Cervical stitches
Cervical stitchesCervical stitches
Cervical stitches
 
Ventose and forceps delivery for undergraduate
Ventose and forceps delivery for undergraduateVentose and forceps delivery for undergraduate
Ventose and forceps delivery for undergraduate
 
SCAR ECTOPIC
SCAR ECTOPICSCAR ECTOPIC
SCAR ECTOPIC
 
Vulval ca and vulval lymph
Vulval ca and vulval lymphVulval ca and vulval lymph
Vulval ca and vulval lymph
 
Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...
Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...
Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...
 
Maternal Death Surveillance and Response
Maternal Death Surveillance and Response Maternal Death Surveillance and Response
Maternal Death Surveillance and Response
 

Similar to Near miss

Clinical study of Eclampsia and outcome in a tertiary care centre
Clinical study of Eclampsia and outcome in a tertiary care centreClinical study of Eclampsia and outcome in a tertiary care centre
Clinical study of Eclampsia and outcome in a tertiary care centreiosrjce
 
Sepsis in pregnancy and postpartum period.
 Sepsis in pregnancy and postpartum period. Sepsis in pregnancy and postpartum period.
Sepsis in pregnancy and postpartum period.mutakha
 
Hospital based study on perinatal mortality in RIMS,Manipur
Hospital based study on perinatal mortality in RIMS,ManipurHospital based study on perinatal mortality in RIMS,Manipur
Hospital based study on perinatal mortality in RIMS,Manipuriosrjce
 
Abortions_Dohbit-/$/7:8_Yaounde_2007.pdf
Abortions_Dohbit-/$/7:8_Yaounde_2007.pdfAbortions_Dohbit-/$/7:8_Yaounde_2007.pdf
Abortions_Dohbit-/$/7:8_Yaounde_2007.pdfJulioJulia3
 
03_Challenge in diagnosis and management of dengue in adults_Dr. Terapong_11 ...
03_Challenge in diagnosis and management of dengue in adults_Dr. Terapong_11 ...03_Challenge in diagnosis and management of dengue in adults_Dr. Terapong_11 ...
03_Challenge in diagnosis and management of dengue in adults_Dr. Terapong_11 ...surgeon8
 
Adrienne Gordon - University of Sydney
Adrienne Gordon - University of SydneyAdrienne Gordon - University of Sydney
Adrienne Gordon - University of SydneyInforma Australia
 
Steve Kirsch - FDA Review
Steve Kirsch - FDA ReviewSteve Kirsch - FDA Review
Steve Kirsch - FDA ReviewAdminIstrator15
 
Maternal mortality
Maternal mortality Maternal mortality
Maternal mortality drmcbansal
 
Dynamic Epidemiology of Streptococcus pneumoniae- Joshua Metlay MD PhD
Dynamic Epidemiology of Streptococcus pneumoniae- Joshua Metlay MD PhDDynamic Epidemiology of Streptococcus pneumoniae- Joshua Metlay MD PhD
Dynamic Epidemiology of Streptococcus pneumoniae- Joshua Metlay MD PhDEastern Pennsylvania Branch ASM
 
Ozzz(maternal mortality)
Ozzz(maternal mortality)Ozzz(maternal mortality)
Ozzz(maternal mortality)Viju Rathod
 

Similar to Near miss (20)

Near miss
Near missNear miss
Near miss
 
Mmr 2016
Mmr 2016Mmr 2016
Mmr 2016
 
Maternal Mortality 2018
Maternal Mortality 2018Maternal Mortality 2018
Maternal Mortality 2018
 
Clinical study of Eclampsia and outcome in a tertiary care centre
Clinical study of Eclampsia and outcome in a tertiary care centreClinical study of Eclampsia and outcome in a tertiary care centre
Clinical study of Eclampsia and outcome in a tertiary care centre
 
Sepsis in pregnancy and postpartum period.
 Sepsis in pregnancy and postpartum period. Sepsis in pregnancy and postpartum period.
Sepsis in pregnancy and postpartum period.
 
Hospital based study on perinatal mortality in RIMS,Manipur
Hospital based study on perinatal mortality in RIMS,ManipurHospital based study on perinatal mortality in RIMS,Manipur
Hospital based study on perinatal mortality in RIMS,Manipur
 
Recurrent Pregnancy Loss
Recurrent Pregnancy LossRecurrent Pregnancy Loss
Recurrent Pregnancy Loss
 
Abortions_Dohbit-/$/7:8_Yaounde_2007.pdf
Abortions_Dohbit-/$/7:8_Yaounde_2007.pdfAbortions_Dohbit-/$/7:8_Yaounde_2007.pdf
Abortions_Dohbit-/$/7:8_Yaounde_2007.pdf
 
03_Challenge in diagnosis and management of dengue in adults_Dr. Terapong_11 ...
03_Challenge in diagnosis and management of dengue in adults_Dr. Terapong_11 ...03_Challenge in diagnosis and management of dengue in adults_Dr. Terapong_11 ...
03_Challenge in diagnosis and management of dengue in adults_Dr. Terapong_11 ...
 
Abortion
AbortionAbortion
Abortion
 
Adrienne Gordon - University of Sydney
Adrienne Gordon - University of SydneyAdrienne Gordon - University of Sydney
Adrienne Gordon - University of Sydney
 
E0342023026
E0342023026E0342023026
E0342023026
 
Steve Kirsch - FDA Review
Steve Kirsch - FDA ReviewSteve Kirsch - FDA Review
Steve Kirsch - FDA Review
 
Siddiqui2009
Siddiqui2009Siddiqui2009
Siddiqui2009
 
Geç Preterm Olguların Yönetimi
Geç Preterm Olguların YönetimiGeç Preterm Olguların Yönetimi
Geç Preterm Olguların Yönetimi
 
Maternal mortality
Maternal mortality Maternal mortality
Maternal mortality
 
Dynamic Epidemiology of Streptococcus pneumoniae- Joshua Metlay MD PhD
Dynamic Epidemiology of Streptococcus pneumoniae- Joshua Metlay MD PhDDynamic Epidemiology of Streptococcus pneumoniae- Joshua Metlay MD PhD
Dynamic Epidemiology of Streptococcus pneumoniae- Joshua Metlay MD PhD
 
CritCareNut2022.pdf
CritCareNut2022.pdfCritCareNut2022.pdf
CritCareNut2022.pdf
 
Ozzz(maternal mortality)
Ozzz(maternal mortality)Ozzz(maternal mortality)
Ozzz(maternal mortality)
 
Eclampsia in Sudan
Eclampsia in SudanEclampsia in Sudan
Eclampsia in Sudan
 

Near miss

  • 1.
  • 2.  Despite therapeutic advances during this century and a growing perception of the safety of child birth, morbidity and mortality continue to occur in obstetric patients. More than one woman dies every TEN minute from such causes.  In addition to maternal death, women experience more than 50 million maternal health problems annualiy.  As many as 300 million women-more than one quarter of all adult women living in the developing world currently suffer from short or Iong term illness and injuries related to pregnancy and child birth.  For every maternal death there are many serious life threatening complications of pregnancy.  Yet relatively little attention has been given to identifying a general category of morbidity that could be called near-misses
  • 3.  The analysis of maternal deaths has long been used for the evaluation of women’ ’s health and the qualityof obstetric care  Over the last decade, the identification of cases of severe maternal morbidity has emerged as a promising complement or alternative to the investigation of maternal deathS.  It has been suggested that with the observed decline in maternal mortality, analysis of well defined near-miss cases may be a more sensitive measure of the standard of obstetric care.  Incorporation of near-misses into maternal death enquiries would strengthen these audits by allowing for more rapid reporting; more robust conclusions, comparisons to be made with maternal deaths, reinforcing lessons learnt, establishing requirement for intensive care and calculating comparative indices
  • 4. WHATS A NEAR MISS?  Every woman can experience sudden and unexpected complications during pregnancy, child birth and just after delivery.  Morbidity during pregnancy represents part of a continuum between extremes of good health and death.  On this continuum a pregnancy may be thought of as being uncomplicated, complicated, severely complicated or life threatening
  • 5.  Near Miss Maternal Mortality is a term which is very difficult to define.Any pregnant women or recently delivered women within 6 weeks of delivery or termination of pregnancy in whom immediate survival is threatened and who survives by the medical intervention and hospital care can be termed as Near Miss  By Mantel GD et al, a near miss describes a patient with acute organ system dysfunction, which if not treated appropriately, could result in death.  Prual A et al, has defined severe maternal morbidity as severe complications from 28th week of gestation to 42nd day postpartum that would have resulted in death of the mother or a definite invalidating sequelae without medical intervention.
  • 6.
  • 7.
  • 8.  In different studies, the primary obstetric causes of severe maternal morbidities have been found to be hypertensive disorders of pregnancy, massive obstetric haemorrhage.  Obstructed labour has been found to be an important cause in some studies.
  • 9.
  • 10.
  • 11. Risk factors The risk factors of severe maternal morbidites have been identified as:  Maternal age >34  social exclusion  Hypertension,  Previous PPH  Delivery by emergency caesarean section,  Multiple pregnancy  Anaemia  Low status of women who do not attend antenatal care in a given health unit but are referred there when they develop life-threatening obstetric complications, contribute significantly to maternal morbidity.  Induced abortions conducted by untrained village midwife (DAI) is still a major cause of morbidity in the developing countries
  • 12. MATERIAL AND METHODS  222 potentially Life threatening cases were studied in a private hospital (Malhotra Nursing Home) in Agra(INDIA) in past five years . And we did a comparison with a rural hospital where we found out about 1080 potentially life threatening cases in past three years.  The main outcome measures were: rate of near miss and its primary determinant factors, criteria for its identification, total hospital stay, ICU stay, and number and kind of special procedures performed.  Complete statistical Analysis was done related to the causes and preventive measures and hospital recovery stay in the study.
  • 13.
  • 14. OUR STATISTICS TOTAL NUMBER Private hospital Rural Hospital OF DELIVERIES (Five years) (Three years) (PAST 5 YRS) NO OF LIVE BIRTHS 1909 6480 NO OF NEAR MISS 32 482 NO OF MATERNAL 0 9 DEATHS NO OF LIVE BIRTHS 19 250 IN NEAR MISS
  • 15. Private Hospital 32 1.67%
  • 16. Rural Hospital 278 482 287 6480 (7.4%) 4.29% MATERNAL MORTALITY- 9
  • 17. POSSIBLY LIFE RURAL HOSP % PRIVATE % THREATENING N= 1080 N=222 CASES PRE- 391 36.5% 122 54.5% ECLAMPSIA/H ELLP HAMEORRHA 270 25% 34 15.3% GE ABRUPTIO 100 10.8% 14 6.3% THROMBOCY 78 7.2% 15 6.7% TOPENIA INFECTION/SE 154 14.2% 8 3.6% PSIS CHD 17 1.5% 8 3.6% PULMONARY 19 1.7% 5 2.2% OEDEMA SICKLE CELL 21 2.0% 4 1.8% JAUNDICE/DIC 30 2.7% 4 1.8%
  • 18. NEAR MISS CASES N =32(private) % N=287(rural) % INTUBATION AND 16 49% 87 31% VENTILATION CLOTTING FAILURE 10 32.2% 30 10.4% BLOOD 8 25.8% 56 19.51% TRANSFUSIONS>5 UNITS THROMBOCYTOPENI 7 22.6% 23 8.2% A HYSTERECTOMY 4 12.9% 17 5.9% RE-EXPLORATION 3 9.7% 29 11% DIALYSIS 1 3.22% 4 1.3% SHOCK 6 19.3% 21 7.3% BILIRUBIN>6mg/dl 4 12.9% 20 7%
  • 19. MATERNAL MORTALITY 0 IN PRIVATE MATERNAL MORTALITY IN 9 RURAL
  • 20.
  • 21.
  • 22. CONCLUSION  Efforts geared towards improvement in the management of near-miss morbidities would definitely go a long way in reducing the present maternal mortality ratio.  From the findings of this review, attempts to reduce maternal deaths may best be achieved by developing evidence-based protocols for the management of severe hypertension and haemorrhage especially for critically ill referred patients.  In addition, considerable efforts should be made to improve maternal care for infrequent but important life-threatening obstetric conditions such as uterine rupture and infection. Necessary facilities should be made available and training of personnel and emergency drills should be frequently conducted to combat the identified disease processes that received suboptimal care.  Although this study did not specifically address avoidable factors, it has nevertheless raised awareness of the deficiencies in the management of serious maternal illnesses